Atossa Therapeutics announces addition of two biopharma executives to team

Atossa Therapeutics (ATOS) announces the engagement of Kathy Puyana Theall, M.D., as Medical Director – Breast Oncology, and Adebola Giwa, M.D., as Medical Director – Rare Diseases. The addition of these two highly experienced physicians and clinical leaders meaningfully strengthens Atossa’s ability to execute on its (Z)-endoxifen development strategy across both breast cancer and rare disease programs, including McCune-Albright syndrome and Duchenne Muscular Dystrophy, as the Company advances toward key clinical and regulatory milestones.